>>> US Close Dow -0.51% S&P -0.27% Nasdaq -0.18% Russell -0.79%

Closing Stock Market Summary
The market exhibited mixed action again. The major indices traded in tight ranges through the morning trade before selling picked up in the afternoon. The Nasdaq Composite registered a 0.2% decline, the S&P 500 logged a 0.3% loss, and the Dow Jones Industrial Average closed 0.5% lower.

This morning's muted price action had a similar feel to other sessions this week. That is to say, a wait-and-see mindset in front of NVIDIA's (NVDA 949.50, -4.36, -0.5%) earnings after Wednesday's close kept the broader market in check.

Selling picked up, however, in response to the Minutes for the April 30-May 1 FOMC meeting. The minutes did not contain anything too surprising and largely echoed Fed commentary since the meeting. The minutes drew attention to asset valuations, which likely fueled some profit taking activity.

Downside moves were relatively modest in many stocks. Target (TGT 143.27, -12.51, -8.0%) was an exception, sliding 8.0% after disappointing earnings and outlook.

Analog Devices (ADI 240.16, +23.52, +10.9%) and First Solar (FSLR 251.75, +39.64, +18.7%) were winning standouts today. The former reported earnings and the latter traded up on a Bloomberg report that China's solar industry body wants an end to the price war.
Only three S&P 500 sectors closed with gains while three sectors declined more than 1.0%.

The 10-yr note yield settled two basis points higher at 4.43% and the 2-yr note yield rose five basis points to 4.88%. This price action was in response to the minutes, but also a hotter-than-expected April CPI report from the U.K., a weaker-than-expected Existing Home Sales report for April.
  • Nasdaq Composite: +11.9% YTD
  • S&P 500:+11.3% YTD
  • S&P Midcap 400: +7.5% YTD
  • Dow Jones Industrial Average: +5.3% YTD
  • Russell 2000: +2.7% YTD

Reviewing today's economic data:
  • Weekly MBA Mortgage Applications Index 1.9%; Prior 0.5%
  • April Existing Home Sales 4.14 mln (consensus 4.20 mln); Prior was revised to 4.22 mln from 4.19 mln
    • The key takeaway from the report is that sales activity was much stronger in the upper-end of the market (homes priced $1 million or more), with inventory up 34% year-over-year and sales up 40% year-over-year, underscoring the idea that there is pent-up demand that can be unleashed when more inventory for lower-priced homes becomes available.
  • Weekly EIA Crude Oil Inventories +1.83M; prior -2.51M

Thursday's economic calendar features:
  • 8:30 ET: Weekly Initial Claims (consensus 219,000; prior 222,000) and Continuing Claims (prior 1.794 mln)
  • 9:45 ET: Flash May S&P Global U.S. Manufacturing PMI (prior 50.0) and flash May S&P Global U.S. Services PMI (prior 51.3)
  • 10:00 ET: April New Home Sales (consensus 680,000; prior 693,000)
  • 10:30 ET: Weekly natural gas inventories (prior +70 bcf)

>>> Cytokinetics and Royalty Pharma (RPRX) announce expanded strategic funding c

Cytokinetics and Royalty Pharma (RPRX) announce expanded strategic funding collaboration totaling up to $575 million to support commercial launch of aficamten and to advance R&D Pipeline (59.23 -0.91)
SOUTH SAN FRANCISCO, Calif. and NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and Royalty Pharma plc (Nasdaq: RPRX) today announced they have entered into a strategic funding collaboration providing capital to support the commercialization of aficamten and advance the company's expanding cardiovascular pipeline while diversifying access to capital as the company advances its muscle biology-directed specialty cardiology business.

>>> Snowflake misses by $0.04, beats on revs, guides for Q2 product revenue grow

Snowflake misses by $0.04, beats on revs, guides for Q2 product revenue growth of 26-27%, FY25 product revenue growth of 24% (163.29 +0.58)
  • Reports Q1 (Apr) earnings of $0.14 per share, excluding non-recurring items, $0.04 worse than the FactSet Consensus of $0.18; revenues rose 32.9% year/year to $828.7 mln vs the $787.4 mln FactSet Consensus.
  • Product revenue for the quarter was $789.6 million, representing 34% year-over-year growth.
  • Remaining performance obligations of $5.0 billion, representing 46% year-over-year growth.
  • Net revenue retention rate of 128%.
  • Co issues guidance for Q2, sees product revenue of $805-$810 mln, representing growth of 26-27%, and non-GAAP operating income margin of 3%.
  • Co issues guidance for FY25, sees product revenue of $3.30 bln, representing growth of 24%, and operating income margin of 3%, adjusted free cash flow margin of 26%.

>>> NVIDIA beats by $0.52, beats on revs; guides Q2 revs above consensus; ten-fo

NVIDIA beats by $0.52, beats on revs; guides Q2 revs above consensus; ten-for-one forward stock split; raises quarterly dividend (949.50 -4.36)
  • Reports Q1 (Apr) earnings of $6.12 per share, excluding non-recurring items, $0.52 better than the FactSet Consensus of $5.60; revenues rose 262.1% year/year to $26.04 bln vs the $24.59 bln FactSet Consensus.
    • Data Center: Revenue was a record $22.6 billion, up 23% from the previous quarter and up 427% from a year ago. These increases reflect higher shipments of the NVIDIA Hopper GPU computing platform used for training and inferencing with large language models, recommendation engines, and generative AI applications.
    • Gaming and AI PC: Revenue was $2.6 billion, down 8% from the previous quarter and up 18% from a year ago. The year-on-year increase primarily reflects higher demand. The sequential decrease reflects seasonally lower GPU sales for laptops.
    • Professional Visualization: Revenue was $427 million, down 8% from the previous quarter and up 45% from a year ago. The year-on-year increase primarily reflects higher sell-in to partners following the normalization of channel inventory levels. The sequential decrease was primarily due to desktop workstation GPUs.
    • Automotive and Robotics: Revenue was $329 million, up 17% from the previous quarter and up 11% from a year ago. The year-on-year increase was driven primarily by self-driving platforms. The sequential increase was driven by AI Cockpit solutions and self-driving platforms.
  • Co issues upside guidance for Q2 (Jul), sees Q2 revs of $28.0 bln +/- 2%, implying $27.44-28.56 bln vs. $26.62 bln FactSet Consensus.
    • GAAP and non-GAAP gross margins are expected to be 74.8% and 75.5%, respectively, plus or minus 50 basis points. For the full year, gross margins are expected to be in the mid-70% range.
  • Co announces ten-for-one forward stock split effective June 7, 2024.
  • Co also announces quarterly cash dividend raised by 150% to $0.01 per share on a post-split basis.